Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

244.13 +3.27 (+1.36%)
Streaming Delayed Price Updated: 1:23 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
News headline image
How Earle Dickson Healed Wound Care With The Band-Aid ↗
When Earle Dickson (1892-1961) invented the Band-Aid, treatments for minor cuts and scrapes were dicey. He changed that. 
Via Investor's Business Daily
News headline image
5 Dividend Stocks Poised to Profit From the AI Efficiency Boom ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing ↗
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing. 
Via Benzinga
Topics Government
News headline image
Johnson & Johnson Unusual Options Activity For June 20 ↗
 
Via Benzinga
News headline image
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices. 
Via Benzinga
News headline image
12 Analysts Have This To Say About Johnson & Johnson ↗
 
Via Benzinga
News headline image
2 Dividend Stocks to Buy and Never Sell ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Peering Into Johnson & Johnson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions
Johnson & Johnson’s first quarter results reflected a steady performance, with the company surpassing Wall Street’s revenue and adjusted profit expectations. Management credited the diversified... 
Via StockStory
Topics Earnings World Trade
News headline image
Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills ↗
The Democratic lawmakers alleged that pharmaceutical companies avoided paying U.S. tax bills by shifting their profits to offshore subsidiaries in jurisdictions with significantly lower tax rates, such... 
Via Stocktwits
Topics Government
News headline image
P/E Ratio Insights for Johnson & Johnson ↗
 
Via Benzinga
News headline image
Johnson & Johnson (NYSE:JNJ) - A Reliable Dividend Stock Worth Considering ↗
Johnson & Johnson (NYSE:JNJ) is a top dividend stock with a 3.32% yield, strong profitability, and a reliable payout history, making it a solid choice for income investors. 
Via Chartmill
News headline image
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead? ↗
Via The Motley Fool
Topics Lawsuit
News headline image
If I Could Invest $1,000 in Any Growth Stock, It Would Be This One ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Government
News headline image
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗
Steady growth and dividend increases over decades can make investors remarkably wealthy. 
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
From Johnson & Johnson
Via Business Wire
News headline image
Rep. Gilbert Ray Cisneros Has Bought Up to $410K Worth Of Johnson & Johnson Stock: Here's What You Should Know ↗
 
Via Benzinga
News headline image
3 Top Dividend Stocks Analysts Are Bullish on Right Now
With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support 
Via MarketBeat
Topics ETFs
News headline image
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug ↗
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives. 
Via Benzinga
News headline image
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point ↗
Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38. 
Via Benzinga
News headline image
Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentation ↗
Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple myeloma patients. 
Via Benzinga
News headline image
5 Cheap Stocks to Buy in June ↗
These stocks are ready for a summer surge. 
Via The Motley Fool
News headline image
Top 3 Reasons Savvy Investors Are Buying Johnson & Johnson Stock While Others Panic Over Lawsuits ↗
For long-term investors looking for both stability and innovation in the healthcare space, JNJ is a rare combination of both. 
Via Talk Markets
News headline image
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire ↗
Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted. 
Via Investor's Business Daily
News headline image
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row ↗
Via The Motley Fool
Topics Bonds
News headline image
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Why Is Teva Stock Trading Higher On Tuesday? ↗
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design. 
Via Benzinga
News headline image
Why Dan Loeb Just Made Kenvue One Of His Top Holdings ↗
Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health company Kenvue Inc. in Q1 2025. 
Via Benzinga
News headline image
1 Top Dividend Stock to Buy for a Lifetime of Passive Income ↗
Via The Motley Fool
Topics Economy Lawsuit
News headline image
Johnson & Johnson (NYSE:JNJ) – A Reliable Dividend Stock Worth Considering ↗
Johnson & Johnson (NYSE:JNJ) offers a strong dividend yield, consistent growth, and solid profitability, making it a compelling choice for income investors. 
Via Chartmill
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS